NASDAQ:BCLI
Brainstorm Cell Therapeutics Inc. Stock News
$0.545
+0.0200 (+3.81%)
At Close: Apr 24, 2024
The Daily Biotech Pulse: Novavax Vaccine Data, Aerpio Gets $5.1M Funding For COVID Trial, Rigel Gains Big On Earnings
12:00am, Wednesday, 05'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 4)
ABIOMED, Inc. (NASDAQ: ABMD) (FDA approved the emergency use of Abiomed's Impella heart pump in combination...
Conformance Technologies Deepens Relationship with InfoSecure Redteam
12:00am, Tuesday, 04'th Aug 2020
InfoSecure Redteam becomes Conformance Cybersecurity to expedite strategic market penetration of products and services via Conformance Technologies.
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
12:00am, Sunday, 02'nd Aug 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.
COVID-19 news flow continued to pour in,...
BrainStorm Cell Therapeutics to Announce Second Quarter Financial Results and Provide a Corporate and R&D Update
11:58am, Monday, 27'th Jul 2020
BrainStorm-Cell Therapeutics Inc. (NASDAQ: BCLI), a leader in developing innovative autologous cellular therapies for highly debilitating neurodegenerative diseases, announced today that the Company w
The Daily Biotech Pulse: Mixed Tidings From Novavax, Radius Health Out-licenses Breast Cancer Drug, 3 IPOs
12:00am, Friday, 24'th Jul 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 23)
Abbott Laboratories (NYSE: ABT)
ABIOMED, Inc. (NASDAQ: ABMD)
Acceleron Pharma Inc (NASDAQ: XLRN)
Aerpio...
5 Stock Gainers for Thursday: Smith & Wesson, Calix, Sunopta
08:36pm, Thursday, 23'rd Jul 2020
Smith & Wesson Brands, Calix, Sunopta, eXp Realty, and Vivent Solar are some of Thursday's movers.
Longtime IIA CEO Richard Chambers plans to step down in March
12:20pm, Thursday, 23'rd Jul 2020
Richard Chambers, who has led the Institute of Internal Auditors for 12 years, will be stepping down effective March 31, 2021. The IIA plans to begin an immediate search for a new CEO.
BrainStorm Announces Groundbreaking Pre-Clinical Study of NurOwn® derived Exosome-Based Treatment for COVID-19 ARDS
11:00am, Thursday, 23'rd Jul 2020
Graph A quantitative analysis for Acute Lung Injury was performed using a severity scoring scale, showed a significant reduction in the severity of lung injury in Nurown exosomes group as compare to c
The Daily Biotech Pulse: Aurinia's Kidney Inflammation Drug Filing Accepted For Review, Intuitive Surgical's Q2 Beat
12:00am, Wednesday, 22'nd Jul 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 21)
ABIOMED, Inc. (NASDAQ: ABMD)
Assembly Biosciences Inc (NASDAQ: ASMB)
Bio-Rad Laboratories, Inc. (NYSE: BIO)...
Insider Weekends: Andrew Spodek Purchases $1 Million Worth Of Postal Realty Trust
11:52am, Monday, 20'th Jul 2020
Insider buying increased last week. Notable Insider Buys: Postal Realty Trust, Inc., Avid Technology, Inc., Brainstorm Cell Therapeutics Inc., Perspecta Inc., and AZZ Inc.
BCLI: KOL Event Gives Overview of the use of NurOwn® in Alzheimer’s Disease; Raising Valuation to $25/Share…
01:10pm, Thursday, 09'th Jul 2020
By David Bautz, PhD NASDAQ:BCLI READ THE FULL BCLI RESEARCH REPORT Business Update KOL Event for Alzheimer’s Program On July 8, 2020, BrainStorm Cell Therapeutics, Inc. (NASDAQ:BCLI) conducted a Key
IIA, IFAC urge audit committees to address coronavirus risks
06:54pm, Wednesday, 08'th Jul 2020
The Institute of Internal Auditors and the International Federation of Accountants are calling on audit committees to be vigilant about risk management, performance, controls and processes during the
BrainStorm Hosting KOL Webinar to Discuss NurOwn® Phase 2 Alzheimer's Disease Program
09:31am, Wednesday, 08'th Jul 2020
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, is hosting a Key Opinion Leader (KOL) webinar on its Alzheimer's Dise
Lineage Cell Therapeutics Announces Extension of OpRegen® Development Grant From Israel Innovation Authority
12:00am, Monday, 06'th Jul 2020
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medic